| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/14651858.CD001797.PUB2 |
| P8608 | Fatcat ID | release_7bewb22o3vczxhjpi6s6ztokhm |
| P698 | PubMed publication ID | 19160200 |
| P50 | author | Filip Eftimov | Q91890454 |
| Ivo N van Schaik | Q91890462 | ||
| P2093 | author name string | John B Winer | |
| Marinus Vermeulen | |||
| Rob de Haan | |||
| P2860 | cites work | Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy | Q70410817 |
| The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange | Q70977781 | ||
| A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy | Q71817931 | ||
| A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy | Q71864965 | ||
| Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves | Q72133927 | ||
| Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy | Q72586505 | ||
| Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy | Q73550695 | ||
| Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin | Q77676625 | ||
| Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases | Q77814999 | ||
| Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial | Q80454073 | ||
| A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy | Q81379967 | ||
| Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy | Q24236599 | ||
| Meta-analyses involving cross-over trials: methodological issues | Q29620304 | ||
| Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group | Q33179842 | ||
| Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study | Q33590410 | ||
| Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy | Q34318837 | ||
| Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin | Q34362734 | ||
| Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England | Q35451141 | ||
| Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy | Q36172657 | ||
| Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy | Q36317688 | ||
| Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials. | Q37207302 | ||
| A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies | Q39508131 | ||
| Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin | Q40746921 | ||
| Measuring quality of life in stroke | Q40869637 | ||
| Future developments in the treatment of immune-mediated polyneuropathies | Q40910694 | ||
| The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity | Q41116085 | ||
| In vitro effects of polyvalent immunoglobulin for intravenous use. | Q41663188 | ||
| On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy | Q41722741 | ||
| An "n of 1" trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy | Q42088641 | ||
| Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement | Q43431737 | ||
| Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy | Q43628763 | ||
| Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. | Q43708051 | ||
| Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy | Q44670941 | ||
| High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study | Q45361840 | ||
| Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria | Q46619488 | ||
| High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy | Q46854866 | ||
| Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study | Q48954233 | ||
| Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness | Q49255435 | ||
| A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. | Q52882065 | ||
| Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange | Q66991230 | ||
| Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy | Q68859537 | ||
| Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy | Q69404597 | ||
| Ocular palsy preceding chronic relapsing polyneuropathy by several weeks | Q70082841 | ||
| Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment | Q70229274 | ||
| P921 | main subject | inflammation | Q101991 |
| chronic inflammatory demyelinating polyradiculoneuropathy | Q1088030 | ||
| P577 | publication date | 2009-01-21 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q36418552 | AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy |
| Q51437085 | Acute pandysautonomia--restitutio ad integrum by high prednisolone therapy. |
| Q26823910 | Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside |
| Q38050751 | Clinical applications of immunoglobulin: update |
| Q37626126 | Clinical applications of intravenous immunoglobulins in neurology |
| Q24201662 | Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q33353548 | First-line treatment for CIDP: a new piece of the puzzle |
| Q24201954 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24236599 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q85018724 | Intravenous IgG for treatment of neuromuscular diseases |
| Q33420267 | Intravenous immunoglobulin as clinical immune-modulating therapy |
| Q37891769 | Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. |
| Q43087483 | Intravenous immunoglobulin treatment in chronic neurological diseases: do we have maintenance dose right? |
| Q39618476 | Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial |
| Q38900642 | Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies. |
| Q30574385 | Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg |
| Q42775420 | New Frontiers in Subcutaneous Immunoglobulin Treatment |
| Q37507924 | Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q34109136 | Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins |
| Q54079344 | Peripheral neuropathies: current evidence for alternative treatment regimens and treatment combinations. |
| Q24187755 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24200900 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q24246631 | Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Q43172858 | Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial |
| Q64118005 | Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study |
| Q30415046 | Therapeutic plasma exchange in neurology: 2012. |
| Q85032476 | Treatment of Chronic Inflammatory Demyelinating Polyneuropathy |
| Q38085792 | Treatment of chronic immune-mediated neuropathies: impact of the rare diseases centers network in Italy |
| Q37557375 | Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations. |
| Q24201434 | Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews |
| Q33870752 | VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy. |
| Q84475530 | [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010] |
Search more.